Ludwig Hantson - Net Worth and Insider Trading

Ludwig Hantson Net Worth

The estimated net worth of Ludwig Hantson is at least $31 Million dollars as of 2024-03-29. Ludwig Hantson is the CEO of Alexion Pharmaceuticals Inc and owns about 150,696 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $28 Million. Ludwig Hantson is also the Corporate Vice President of Baxter International Inc and owns about 83,903 shares of Baxter International Inc (BAX) stock worth over $4 Million. Details can be seen in Ludwig Hantson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ludwig Hantson has not made any transactions after 2018-12-31 and currently still holds the listed stock(s).

Transaction Summary of Ludwig Hantson

To

Ludwig Hantson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ludwig Hantson owns 4 companies in total, including Alexion Pharmaceuticals Inc () , Hologic Inc () , and Baxalta Inc () among others .

Click here to see the complete history of Ludwig Hantson’s form 4 insider trades.

Insider Ownership Summary of Ludwig Hantson

Ticker Comapny Transaction Date Type of Owner
Alexion Pharmaceuticals Inc 2020-03-30 director & CEO
Hologic Inc 2018-11-21 director
Baxalta Inc 2016-06-03 director & President and CEO
Baxter International Inc 2015-06-01 Corporate Vice President

Ludwig Hantson Latest Holdings Summary

Ludwig Hantson currently owns a total of 2 stocks. Among these stocks, Ludwig Hantson owns 150,696 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 31, 2018, with a value of $28 Million and a weighting of 88.46%. Ludwig Hantson also owns 83,903 shares of Baxter International Inc (BAX) as of July 9, 2014, with a value of $4 Million and a weighting of 11.54%.

Latest Holdings of Ludwig Hantson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2018-12-31 150,696 182.50 27,502,020
BAX Baxter International Inc 2014-07-09 83,903 42.74 3,586,014

Holding Weightings of Ludwig Hantson


Ludwig Hantson Form 4 Trading Tracker

According to the SEC Form 4 filings, Ludwig Hantson has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 3,244 shares on December 31, 2018, which brought Ludwig Hantson around $310,937.

According to the SEC Form 4 filings, Ludwig Hantson has made a total of 0 transactions in Baxter International Inc (BAX) over the past 5 years. The most-recent trade in Baxter International Inc is the sale of 24,693 shares on July 9, 2014, which brought Ludwig Hantson around $2 Million.

Insider Trading History of Ludwig Hantson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ludwig Hantson Trading Performance

GuruFocus tracks the stock performance after each of Ludwig Hantson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ludwig Hantson is 22.55%. GuruFocus also compares Ludwig Hantson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ludwig Hantson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ludwig Hantson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ludwig Hantson

Average Relative Return

1.83%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 7.38 22.55 -4.16 1.83 -0.03 -2.52
Relative Return to S&P 500(%) 6.5 20.18 -12.94 -12.3 -8.85 -10.18

Ludwig Hantson Ownership Network

Ownership Network List of Ludwig Hantson

No Data

Ownership Network Relation of Ludwig Hantson


Ludwig Hantson Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Ludwig Hantson is the director & CEO of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Ludwig Hantson Mailing Address

Above is the net worth, insider trading, and ownership report for Ludwig Hantson. You might contact Ludwig Hantson via mailing address: C/o Alexion Pharmaceuticals, Inc, 100 College Street, New Haven Ct 06510.

Discussions on Ludwig Hantson

No discussions yet.